TrialX
Image

Role of CEUS as a Secondary Diagnostic Modality

Role of CEUS as a Secondary Diagnostic Modality

Recruiting
18 years and older
All
Phase N/A

Overview

To determine the role of contrast-enhanced ultrasound (CEUS) as a second-line imaging modality after gadoxetate-enhanced MRI (Gd-EOB-MRI) for identifying hepatocellular carcinoma (HCC) among at-risks observations.

Description

The purpose of our study was to evaluate the diagnostic ability of CEUS with perflubutane to identify HCC on the indeterminate observation in Gd-EOB-MRI and to establish the role of CEUS as a second-line (post-Gd-EOB-MRI) modality for HCC diagnosis.

Eligibility

Inclusion Criteria:

  • at risk of HCC by Liver Imaging Reporting and Data System (LI-RADS)
  • at least one treatment-nave solid hepatic observation (1 cm) while surveillance using US, CT or MRI
  • signed informed consent

Exclusion Criteria:

  • congestive hepatopathies
  • severe cardiovascular dysfunction
  • no recent cross-sectional images within 4 weeks
  • suboptimal cross-sectional images quality

Study details
    Adenocarcinoma
    Adenocarcinoma
    HEPATIC NEOPLASM
    liver cancer
    HEPATOCELLULAR CARCINOMA
    liver cancer

NCT04494022

Seoul National University Hospital

5 August 2020

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.